Cell and gene therapy shipments must meet varying global regulations to avoid costly delays. Improper storage methods can lead to wasted materials and increased costs, impacting pharmaceutical companies and patient outcomes. With these transformative drugs being expensive to manufacture, logistics best practices are crucial to prevent spoilage and ensure timely delivery. As 3PL providers gear up for the influx of cell and gene therapies, optimizing logistics operations becomes essential for successful treatment outcomes and cost-effective production. Compliance with regulations and efficient handling are paramount to avoid setbacks and ensure patients worldwide benefit from these innovative therapies.
Read more from pharmaceutical-technology.com
